Acute Lymphoblastic Leukemia Market to Surpass USD 4.5 billion with CAGR 7.6% by 2031,TMR Report
October 05, 2023 07:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute lymphoblastic leukemia market was estimated to have acquired US$ 2.2 billion in...
Hairmax Partners with Breastcancer.org to support Breast Cancer Awareness Month
October 03, 2023 08:59 ET
|
Hairmax
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in hair growth transformation, announced today that it will donate a percentage of sales during the month...
Global Cancer Pain Market 2023-2028: Eli Lilly & Company and Johnson & Johnson at the Forefront of Personalized Pain Management for Cancer Patients
September 28, 2023 05:28 ET
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market (2023-2028) by Type, Disease Indication, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...
Triple-Negative Breast Cancer Treatment Market Size to Surpass US$ 20 Billion by 2030
September 25, 2023 14:45 ET
|
Zion Market Research
NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Triple-Negative Breast Cancer Treatment Market By Drug Type...
Glioma Treatment Market worth $8.29 Billion by 2030 - Exclusive Report by The Insight Partners
September 22, 2023 08:54 ET
|
The Insight Partners
Pune, India, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Glioma is a condition that covers a broad category of brain and spinal cord tumors that concern the glial cells in the brain function and can be fatal...
Metastatic Cancer Drug Market Thrives with Collaborative Innovations: Pfizer, Sanofi, and Merck Leading the Charge
September 15, 2023 10:18 ET
|
Research and Markets
Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted...
AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia
September 12, 2023 03:00 ET
|
AlgoTX
PARIS, Sept. 12, 2023 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing targeted, first-in-class therapeutics for peripheral neuropathic pain,...
Global Cancer Therapeutics Market (2023-2028): Cancer Chemotherapy Dominates Market - A Closer Look at Therapeutic Types
September 07, 2023 05:58 ET
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of...
Urothelial Carcinoma Treatment Market revenue to exceed USD 5 Billion by 2035, says Research Nester
August 30, 2023 06:00 ET
|
Research Nester
New York, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The global Urothelial Carcinoma Treatment Market size is predicted to expand at ~ 21 % CAGR between 2023 and 2035. The market is projected to garner a...
Global Amyotrophic Lateral Sclerosis Market Size to Reach USD 1,034.7 Million in 2032 | Emergen Research
August 29, 2023 08:56 ET
|
Emergen Research
Vancouver, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The worldwide market for amyotrophic lateral sclerosis achieved a size of USD 613.0 million in the year 2022. According to the most recent study...